Tris Pharma Hires Seasoned Research & Development Executive
Alfred Liang to join as Vice President, Research & Development
News provided by
Share this article
Share this article
MONMOUTH JUNCTION, N.J., Dec. 18, 2020 /PRNewswire/ Tris Pharma, Inc. ( Tris ), a specialty pharmaceutical company with a robust portfolio of approved products and a late-stage pipeline of innovative product candidates for the treatment of Attention Deficit Hyperactivity Disorder and related disorders, today announced that Dr. Alfred C. Liang will join the company as Vice President, Research & Development effective January 4, 2021. With our continued growth and evolution to a larger, more complex operation, one of our priorities has been to bring a seasoned pharmaceutical development leader in to join Tris senior leadership team. We are thrilled that Alfred has agreed to join Tris as our Vice President, Research & Development. said Ketan Mehta Tris Founder and Chief Executive Officer. Alfred s